HK1169826A1 - Azilsartan organic amine salts, process of preparing them and the use thereof - Google Patents

Azilsartan organic amine salts, process of preparing them and the use thereof

Info

Publication number
HK1169826A1
HK1169826A1 HK12110538.4A HK12110538A HK1169826A1 HK 1169826 A1 HK1169826 A1 HK 1169826A1 HK 12110538 A HK12110538 A HK 12110538A HK 1169826 A1 HK1169826 A1 HK 1169826A1
Authority
HK
Hong Kong
Prior art keywords
preparing
organic amine
amine salts
azilsartan organic
azilsartan
Prior art date
Application number
HK12110538.4A
Other languages
English (en)
Chinese (zh)
Inventor
潘必高
黃龍彬
楊寶海
Original Assignee
江蘇豪森醫藥集團有限公司 江蘇省
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江蘇豪森醫藥集團有限公司 江蘇省 filed Critical 江蘇豪森醫藥集團有限公司 江蘇省
Publication of HK1169826A1 publication Critical patent/HK1169826A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12110538.4A 2011-01-20 2012-10-23 Azilsartan organic amine salts, process of preparing them and the use thereof HK1169826A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110022311 2011-01-20

Publications (1)

Publication Number Publication Date
HK1169826A1 true HK1169826A1 (en) 2013-02-08

Family

ID=46515148

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12110538.4A HK1169826A1 (en) 2011-01-20 2012-10-23 Azilsartan organic amine salts, process of preparing them and the use thereof

Country Status (13)

Country Link
US (1) US9233954B2 (es)
EP (1) EP2666773B1 (es)
JP (1) JP5981940B2 (es)
CN (1) CN102603723B (es)
AU (1) AU2012208863B2 (es)
BR (1) BR112013017982A2 (es)
CA (1) CA2824316C (es)
HK (1) HK1169826A1 (es)
MX (1) MX340590B (es)
RU (1) RU2600986C2 (es)
TW (1) TWI519531B (es)
WO (1) WO2012097697A1 (es)
ZA (1) ZA201305059B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103113364B (zh) * 2012-08-27 2015-11-18 南京华威医药科技开发有限公司 阿齐沙坦多晶型的制备方法
CN103601723B (zh) * 2013-11-19 2016-04-27 合肥远志医药科技开发有限公司 一种阿齐沙坦的工业化生产方法
JP2017036215A (ja) * 2013-12-27 2017-02-16 トーアエイヨー株式会社 アンジオテンシンｉｉ受容体拮抗物質の塩
CN105037341B (zh) * 2014-04-04 2019-12-03 江苏豪森药业集团有限公司 阿齐沙坦醇铵晶型及其制备方法
CN105503848A (zh) * 2014-10-13 2016-04-20 江苏豪森药业集团有限公司 阿齐沙坦有机胺盐复合物及其制备方法和用途
CZ2014702A3 (cs) 2014-10-15 2016-04-27 Zentiva, K.S. Způsob přípravy vysoce čistého azilsartanu
CN108113988A (zh) * 2016-11-29 2018-06-05 江苏恒瑞医药股份有限公司 一种romk抑制剂与arb联合在制备治疗和/或预防高血压或心力衰竭的药物中的用途
CN107286145A (zh) * 2017-08-14 2017-10-24 广州奈米微晶生物科技有限公司 一种阿齐沙坦哌嗪盐溶剂合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
ZA924666B (en) * 1991-06-27 1993-12-24 Takeda Chemical Industries Ltd Heterocyclic compounds, their production and use
DE60135560D1 (de) * 2000-07-19 2008-10-09 Novartis Ag Valsartan salze
AU2002349673A1 (en) * 2001-12-03 2003-06-17 Takeda Chemical Industries, Ltd. Insulin resistance improving agents
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
US7157584B2 (en) 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
RU2007116969A (ru) * 2004-10-07 2008-11-20 Такеда Фармасьютикал Компани Лимитед (Jp) Средство для профилактики или лечения метаболического синдрома
SI22297A (sl) * 2006-06-23 2007-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava soli telmisartana
CZ2008469A3 (cs) * 2008-07-31 2009-10-29 Zentiva, A. S. Telmisartan tablety
WO2010075347A2 (en) 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
CN101921264A (zh) * 2009-06-15 2010-12-22 江苏豪森医药集团有限公司 坎地沙坦有机胺盐及其制备方法和用途
US20120238606A1 (en) * 2009-11-30 2012-09-20 Jiangsu Hans Pharmaceutial Group Co., Ltd. Azilsartan organic amine salts, preparation method and use thereof

Also Published As

Publication number Publication date
AU2012208863A1 (en) 2013-08-01
ZA201305059B (en) 2015-01-28
US20130296334A1 (en) 2013-11-07
CN102603723A (zh) 2012-07-25
EP2666773B1 (en) 2017-07-26
EP2666773A8 (en) 2014-02-12
CA2824316C (en) 2020-07-07
EP2666773A4 (en) 2014-06-11
TWI519531B (zh) 2016-02-01
AU2012208863B2 (en) 2016-07-28
TW201309684A (zh) 2013-03-01
JP2014502978A (ja) 2014-02-06
RU2013137223A (ru) 2015-02-27
CN102603723B (zh) 2014-10-08
MX2013008197A (es) 2013-11-22
WO2012097697A1 (zh) 2012-07-26
CA2824316A1 (en) 2012-07-26
RU2600986C2 (ru) 2016-10-27
BR112013017982A2 (pt) 2020-10-27
MX340590B (es) 2016-07-13
EP2666773A1 (en) 2013-11-27
US9233954B2 (en) 2016-01-12
JP5981940B2 (ja) 2016-08-31

Similar Documents

Publication Publication Date Title
IL242278A0 (en) Compounds 4)-n-fluoro-2-methoxy-5-nitrophenyl)pyrimidine-2-converted amine and their salts
IL231591A (en) Preserved benzyl indazoles, a process for their preparation and use
HK1198824A1 (en) Mixtures of aluminium hydrogenphosphites with aluminium salts, process for the production thereof and the use thereof
ZA201307815B (en) N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides
EP2679592A4 (en) NEW HETEROCYCLIC COMPOUND, PROCESS FOR PRODUCING INTERMEDIATE PRODUCTS THEREOF AND USE THEREOF
IL230477A0 (en) Process for preparing 2,2-difluoroethanol
HK1169826A1 (en) Azilsartan organic amine salts, process of preparing them and the use thereof
LT2489670T (lt) Aminorūgščių chelatinių junginių gavimo būdas, aminorūgščių chelatiniai junginiai ir aminorūgščių chelatinių junginių panaudojimas
ZA201308180B (en) Multifunctional primary amine, process for its preparation, and use thereof
PL2678035T3 (pl) Pochodne fenalen-1-onu, sposób ich wytwarzania i zastosowanie
PT2751073T (pt) Processo para a preparação de isocianatos
EP2676965A4 (en) ARYLGLYCOSIDE COMPOUND, MANUFACTURING METHOD AND APPLICATION THEREOF
EP2763998A4 (en) TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
SI2602805T1 (sl) Ohišje za napravo za prenapetostno zaščito in ustrezna naprava za prenapetostno zaščito
EP2881385A4 (en) NOVEL AZO COMPOUND, USE THEREOF AND METHOD FOR THE PRODUCTION THEREOF
HK1164310A1 (en) Azilsartan organic amine salts, preparation method and use thereof
HK1202289A1 (en) Chemical process for preparing spiroindolones and intermediates thereof
PL2756883T3 (pl) Sposób otrzymywania 2,3,3,3-tetrafluoropropenu
EP2778168A4 (en) PYRROLO-PYRROLEDION-THENCHINONE COMPOUND AND METHOD OF MANUFACTURING THEREOF
EP2650281A4 (en) PROCESS FOR PREPARING CYCLIC AMINE COMPOUNDS
IL227544A0 (en) Leoplomide and its enantiomers, a method for their preparation and medical uses thereof
EP2690085A4 (en) NORBORNENE ESTER DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USES THEREOF
EP2731926A4 (en) METHOD FOR PRODUCING AN AMINONITRILE AND DIAMINE, AND CORRESPONDING DEVICES
IL232630A0 (en) A method for the preparation of 6,2-difluoroacetophenones
PL2771328T3 (pl) Sposób otrzymywania 1,2-benzizotiazolin-3-onu

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220111